Lactosylceramide 4-alpha-galactosyltransferase (A4GALT)

Homo sapiens — UniProt Q9NPC4

Gene: A4GALTHomo sapiensSwissProt reviewed

About Lactosylceramide 4-alpha-galactosyltransferase

Lactosylceramide 4-alpha-galactosyltransferase (A4GALT) is a protein from Homo sapiens identified by UniProt accession Q9NPC4, 353 residues long. MolForge cross-references it against 0 known binders and 63 disease associations.

Target properties

Protein nameLactosylceramide 4-alpha-galactosyltransferase
UniProt accessionQ9NPC4
GeneA4GALT
OrganismHomo sapiens
Length353 residues
Molecular weight—
EC numbers—
Target classUNCLASSIFIED
Subcellular location—
Keywords—

Druggability

Target tractability assessment (Open Targets + pocket analysis). No approved drug

Druggability tierMEDIUM
Druggability score—
Pocket score—
Max clinical phase—

3D Structure (1)

Experimental (PDB) and predicted (AlphaFold) structures for this protein.

StructureSourceMethodMean pLDDTResolution (Å)
AF-Q9NPC4-F1alphafoldPREDICTED89.26—

Amino-acid sequence (353 residues)

MSKPPDLLLR LLRGAPRQRV CTLFIIGFKF TFFVSIMIYW HVVGEPKEKG QLYNLPAEIP CPTLTPPTPP SHGPTPGNIF FLETSDRTNP NFLFMCSVES AARTHPESHV LVLMKGLPGG NASLPRHLGI SLLSCFPNVQ MLPLDLRELF RDTPLADWYA AVQGRWEPYL LPVLSDASRI ALMWKFGGIY LDTDFIVLKN LRNLTNVLGT QSRYVLNGAF LAFERRHEFM ALCMRDFVDH YNGWIWGHQG PQLLTRVFKK WCSIRSLAES RACRGVTTLP PEAFYPIPWQ DWKKYFEDIN PEELPRLLSA TYAVHVWNKK SQGTRFEATS RALLAQLHAR YCPTTHEAMK MYL

Explore Lactosylceramide 4-alpha-galactosyltransferase with MolForge

Find binders, run structure-based screening, and map this target across diseases and approved drugs with our AI-powered platform.

Browse all targets

Quick facts

UniProtQ9NPC4
GeneA4GALT
OrganismHomo sapiens
Length353
Binders0
Diseases63
View on UniProt